Nick Reader, MD, MPH – CEO and Founder Alpenglow Biosciences, MD, MPH
CEO and Founder at Alpenglow Biosciences
Nick received a B.S. in biochemistry from the University of Michigan, an M.P.H. in epidemiology from Emory University, and an M.D. from Loyola University Chicago before receiving his pathology training at University of Washington, where he completed an anatomic pathology residency followed by a genitourinary pathology fellowship. While in residency, Nick co-invented open-top light-sheet microscopy with Dr. Jonathan Liu, Dr. Adam Glaser, and Dr. Larry True, winning the Castleman Award in 2018. The founding team spun out the technology from the University of Washington and Nick became CEO of Alpenglow Biosciences in 2019, with a goal of applying 3D spatial biology technology towards accelerating drug discovery.